On February 28th, the two projects of agricultural science and technology achievement transformation funded by the Yangtze Institute of the Academy of Water Sciences, "Pilot and demonstration of compound pond aquaculture ecosystems" and "Pilot trials and demonstrations of bacteriological vaccines for freshwater cultured animals such as Chinese sturgeon," passed agriculture. Experts organized by the Department of Science and Education accepted.
“Comprehensive pond aquaculture ecosystem pilot test and demonstration†has established three pilot and demonstration bases through a compound ditch wetland-pond aquaculture ecosystem, a compound rice paddy-pond aquaculture ecosystem, and a compound biological pond-pond aquaculture ecosystem. Mu, the technology is further matured, and the application effect is remarkable. In the project implementation period, the demonstration base will form a set of comprehensive pond aquaculture ecosystem management standards that can be promoted and applied, with a total sales income of 2.225 million yuan, a net profit of 657,900 yuan, an aquaculture production increase of 20% or more, and an increase in economic efficiency of more than 30%. More than 60% reduction of pollutants, saving more than 50%. During the implementation of the project, 15 papers were published, 3 patents were obtained, 25 new employees were employed, and the total number of training personnel was 550. Achieved better social and ecological benefits.
"Pilot Test and Demonstration of Bacterial Disease Vaccines in Freshwater Breeding Animals with Chinese Sturgeon etc." completed 2 sets of application materials for the Chinese sturgeon aeromonas hydrophila vaccine and the inactivated vaccine for channel catfish hemorrhagic disease, of which the former was approved by the Ministry of Agriculture of the Ministry of Agriculture. . To build a GMP vaccine production workshop with an annual production capacity of 20 million milliliters, and to improve the production technology, medium composition, dosage forms, and packaging materials of the inactivated bacterial vaccines. Cumulative production of Chinese wolfberry hydrophila vaccine was 2.0199 million milliliters, achieving a production value of 403,800 yuan. The relative immune protection rates in clinical trials were 80% and 86.7%, respectively, and the survival rates were 16.04% and 13.36%, respectively. The relative immune protection rate of immersed immature larvae was 73.5% and the survival rate was 14.3-30%. During the implementation of the project, 4 training sessions were held and 750 person-times. Technical consultation, guidance and product application activities were conducted 30 times, and 2 papers were published.
“Comprehensive pond aquaculture ecosystem pilot test and demonstration†has established three pilot and demonstration bases through a compound ditch wetland-pond aquaculture ecosystem, a compound rice paddy-pond aquaculture ecosystem, and a compound biological pond-pond aquaculture ecosystem. Mu, the technology is further matured, and the application effect is remarkable. In the project implementation period, the demonstration base will form a set of comprehensive pond aquaculture ecosystem management standards that can be promoted and applied, with a total sales income of 2.225 million yuan, a net profit of 657,900 yuan, an aquaculture production increase of 20% or more, and an increase in economic efficiency of more than 30%. More than 60% reduction of pollutants, saving more than 50%. During the implementation of the project, 15 papers were published, 3 patents were obtained, 25 new employees were employed, and the total number of training personnel was 550. Achieved better social and ecological benefits.
"Pilot Test and Demonstration of Bacterial Disease Vaccines in Freshwater Breeding Animals with Chinese Sturgeon etc." completed 2 sets of application materials for the Chinese sturgeon aeromonas hydrophila vaccine and the inactivated vaccine for channel catfish hemorrhagic disease, of which the former was approved by the Ministry of Agriculture of the Ministry of Agriculture. . To build a GMP vaccine production workshop with an annual production capacity of 20 million milliliters, and to improve the production technology, medium composition, dosage forms, and packaging materials of the inactivated bacterial vaccines. Cumulative production of Chinese wolfberry hydrophila vaccine was 2.0199 million milliliters, achieving a production value of 403,800 yuan. The relative immune protection rates in clinical trials were 80% and 86.7%, respectively, and the survival rates were 16.04% and 13.36%, respectively. The relative immune protection rate of immersed immature larvae was 73.5% and the survival rate was 14.3-30%. During the implementation of the project, 4 training sessions were held and 750 person-times. Technical consultation, guidance and product application activities were conducted 30 times, and 2 papers were published.
Dental Instrument Series,Saliva Ejector,Dental Saliva Ejectors,Dental Material Ejector
Ningbo Carest Medical Instrument Co.,ltd , https://www.carestmed.com